New clinical trials in Argentina: 529 since Nov 2024

Name: New clinical trials in Argentina
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New clinical trials with a site in Argentina: 529 rows for $26.45, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 14 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/country/argentina, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 9, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

529 clinical studies with a site in Argentina were first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026; 423 have an industry sponsor and 378 are recruiting or about to. The newest, NCT07926087, was posted on November 9, 2026: Efficacy of Different Doses of Bezafibrate in Combination With Ursodeoxycholic Acid in Patients With Primary... (Instituto de Biotecnologia de Misiones).

The request: Every new clinical trial with a site in Argentina, with the sponsor, phase, conditions and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

529New trials
423Industry sponsored
378Recruiting or not yet
November 9, 2026Latest posted

Newest trials

The newest 100 of 529, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 9, 2026	NCT07926087	Efficacy of Different Doses of Bezafibrate in Combination With Ursodeoxycholic Acid in Patients With Primary Biliary Cholangitis	Instituto de Biotecnologia de Misiones	Phase 4	Completed	Primary Biliary Cholangitis (PBC)	60	Argentina	clinicaltrials.gov
November 5, 2026	NCT07919405	A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Hypertension, Obesity	1,408	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Denmark, Germany...	clinicaltrials.gov
November 4, 2026	NCT07915219	A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)	Boehringer Ingelheim	Phase 3	Not yet recruiting	Bronchiectasis	1,500	Argentina, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China, Czechia...	clinicaltrials.gov
October 30, 2026	NCT07908108	Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma...	Istituto Giannina Gaslini	Observational	Active not recruiting	Scleroderma	272	Argentina, Brazil, China, Croatia, Denmark, Egypt, Germany, Greece, India...	clinicaltrials.gov
October 28, 2026	NCT07900633	A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2	3,000	Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary...	clinicaltrials.gov
October 23, 2026	NCT07892378	Multiparametric Magnetic Resonance Imaging (mpMRI) Versus Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET) for...	Sanatorio Privado San Geronimo	Observational	Not yet recruiting	Prostate Cancer	65	Argentina	clinicaltrials.gov
October 22, 2026	NCT07890480	Aztreonam-Avibactam in Immunocompromised Hosts	Centro de Educación Medica e Investigaciones Clínicas Norberto Quirno	Observational	Recruiting	Enterobacteriaceae Infections, Carbapenem-Resistant Enterobacteriaceae Infection, Immunocompromised Host, Drug...	814	Argentina	clinicaltrials.gov
October 22, 2026	NCT07890376	A Study to Investigate the Effect of LY4086940 Versus Placebo in Participants With Obesity or Overweight and Without Type 2 Diabetes	Eli Lilly and Company	Phase 2	Not yet recruiting	Obesity, Overweight	460	Argentina, United States	clinicaltrials.gov
October 19, 2026	NCT07881432	A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes	Eli Lilly and Company	Phase 3	Not yet recruiting	Obesity	2,115	Argentina, China, Germany, India, Japan, Puerto Rico, South Korea, United...	clinicaltrials.gov
October 15, 2026	NCT07875595	Immune Biomarkers for Predicting Complications After Liver Transplantation	Hospital Italiano de Buenos Aires	Observational	Recruiting	Liver Transplantation (LT), Immuno-suppression, Biomarkers / Blood, Rejection, Infections	60	Argentina	clinicaltrials.gov
October 15, 2026	NCT07875257	Evaluation of an Adaptive Neurotechnology Based on Motor Imagery in Patients Who Suffered a Left Hemisphere Stroke	Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia	Not applicable	Enrolling by invitation	Stroke, Brain Computer Interface, Motor Imagery, Neurofeedback, Upper Extremity, Rehabilitation	20	Argentina	clinicaltrials.gov
October 14, 2026	NCT07873424	Recumbent Cycling and Functional Electrical Stimulation for Lower Limb Rehabilitation	National Council of Scientific and Technical Research, Argentina	Not applicable	Recruiting	Muscle Fatigue, Functional Electrical Stimulation, Neuromuscular Rehabilitation	30	Argentina	clinicaltrials.gov
October 8, 2026	NCT07865923	Clinical Trial for the Study of Stress and Exercise Impact on Glucose Levels and Additional Physiological Signals. Stress, Insulin and...	National Council of Scientific and Technical Research, Argentina	Not applicable	Completed	Type 1 Diabetes (T1D)	5	Argentina	clinicaltrials.gov
October 6, 2026	NCT07861100	A Research Study to Look at How Well Zenagamtide Works Compared to Placebo in People With Established Atherosclerotic Cardiovascular...	Novo Nordisk A/S	Phase 3	Not yet recruiting	Cardiovascular Risk, Obesity	8,500	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark...	clinicaltrials.gov
October 1, 2026	NCT07851025	Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Non-Homologous Recombination Deficiency (Non-HRD) Positive Advanced...	AstraZeneca	Phase 3	Recruiting	Epithelial Ovarian Cancer	950	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Colombia...	clinicaltrials.gov
September 28, 2026	NCT07845253	Effect of Limosilactobacillus Reuteri on Social Deficits in Children With Autistic Spectrum Disorder	BioGaia AB	Not applicable	Not yet recruiting	Autism Spectrum Disorder	200	Argentina	clinicaltrials.gov
September 25, 2026	NCT07843225	Standard Closure vs. Integrated Mesh-Fascial Closure (IMFC) for Incisional Hernia Repair	Hospital Zonal General De Agudos Mario V Larrain	Not applicable	Recruiting	Incisional Hernia Repair, Ventral Incisional Hernia	60	Argentina	clinicaltrials.gov
September 21, 2026	NCT07830732	A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A	Novo Nordisk A/S	Phase 3	Recruiting	Haemophilia A	84	Argentina, Australia, Brazil, Canada, Denmark, France, Germany, Greece, India...	clinicaltrials.gov
September 14, 2026	NCT07818109	One Health Determinants of Rectal Colonization by ESBL-Producing Enterobacterales in the Community	Hospital Italiano de Buenos Aires	Observational	Enrolling by invitation	Antimicrobial Resistance (AMR), ESBL, Gut Microbiota Dysbiosis, Environmental Exposure, Carbapenemase-Producing...	432	Argentina	clinicaltrials.gov
September 10, 2026	NCT07812142	Retrospective Analysis of the Second Year of Safety Surveillance of the Qdenga® (TAK-003) Vaccine in Private Vaccination Centers, Including...	Fundación Vacunar	Observational	Active not recruiting	Dengue Vaccines	94,526	Argentina	clinicaltrials.gov
September 9, 2026	NCT07811193	A Study to Evaluate the Efficacy of VVD-133214 in Combination With Pembrolizumab Compared With Pembrolizumab Alone in Participants With...	Vividion Therapeutics, Inc.	Phase 2	Recruiting	Colorectal Adenocarcinoma	140	Argentina, Belgium, Brazil, China, France, Germany, Greece, Hong Kong, Italy...	clinicaltrials.gov
September 9, 2026	NCT07808697	A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 in Participants ≥6 Months to <12 Years of Age	ModernaTX, Inc.	Phase 2	Recruiting	SARS-CoV-2	300	Argentina, Dominican Republic, Mexico, Panama, Puerto Rico, United States	clinicaltrials.gov
September 3, 2026	NCT07801742	EFFECT OF ZOLPIDEM ON SLEEP QUALITY AND OPIOID CONSUMPTION FOLLOWING PRIMARY TOTAL KNEE ARTHROPLASTY: A PROSPECTIVE, RANDOMIZED...	Sanatorio Allende	Phase 4	Completed	Postoperative Pain Management in Total Knee Arthroplasty	54	Argentina	clinicaltrials.gov
September 1, 2026	NCT07797569	Prevalence of Multidrug-Resistant Organism Infections in General Adult Wards in Argentina (PREV-AR 2 - IGA)	Hospital Italiano de Buenos Aires	Observational	Active not recruiting	Multidrug-Resistant Organism Infection, Healthcare-Associated Infections (HAIs), Antimicrobial Resistance (AMR)	2,000	Argentina	clinicaltrials.gov
September 1, 2026	NCT07797335	AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People...	Novo Nordisk A/S	Phase 3	Recruiting	Type 2 Diabetes, Cardiovascular Risk	1,778	Argentina, Brazil, Bulgaria, Canada, China, Czechia, Germany, Greece, India...	clinicaltrials.gov
August 31, 2026	NCT07794579	A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1...	Eli Lilly and Company	Phase 3	Recruiting	Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal	2,001	Argentina, China, Czechia, Germany, India, Japan, Mexico, Puerto Rico, South...	clinicaltrials.gov
August 28, 2026	NCT07792031	Comparing the Effect of Two Types of Pelvic Floor Muscle Stimulation Devices to Improve Symptoms of Urinary Incontinence in Women.	Espacio Gaspar Clinic	Not applicable	Recruiting	Urinary Incontinence, Mixed Urinary Incontinence, Urinary Incontinence (UI), Stress Urinary Incontinence (SUI), Stress...	58	Argentina	clinicaltrials.gov
August 28, 2026	NCT07789483	An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy	Alexion Pharmaceuticals, Inc.	Phase 3	Not yet recruiting	Transthyretin Amyloid Cardiomyopathy (ATTR-CM)	1,180	Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia...	clinicaltrials.gov
August 27, 2026	NCT07791043	A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver...	GlaxoSmithKline	Phase 2	Recruiting	Liver Diseases, Alcoholic	274	Argentina, Canada, South Korea, United States	clinicaltrials.gov
August 27, 2026	NCT07789015	A Study to Understand How Nerandomilast Works in People With Active Idiopathic Inflammatory Myopathies	Boehringer Ingelheim	Phase 3	Not yet recruiting	Idiopathic Inflammatory Myopathies	270	Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, China, Czechia...	clinicaltrials.gov
August 26, 2026	NCT07787767	CMV Refractory and Resistant Infection in Solid Organ Transplant Recipients in Argentina	Hospital Italiano de Buenos Aires	Observational	Not yet recruiting	Cytomegalovirus Infections, Solid Organ Transplantation Recipient, Solid Organ Transplantation	200	Argentina	clinicaltrials.gov
August 25, 2026	NCT07784725	A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2...	AstraZeneca	Phase 3	Recruiting	Obesity or Overweight	2,500	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, France...	clinicaltrials.gov
August 25, 2026	NCT07784270	A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight	AstraZeneca	Phase 3	Recruiting	Obesity or Overweight, Diabetes Mellitus, Type 2	1,500	Argentina, Australia, Canada, Chile, China, Germany, Hungary, India, Japan...	clinicaltrials.gov
August 25, 2026	NCT07783802	A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event	Eli Lilly and Company	Phase 2	Recruiting	Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic	120	Argentina, Japan, Puerto Rico, United States	clinicaltrials.gov
August 20, 2026	NCT07777523	Non-invasive Testing for End-Stage Chronic Kidney Disease	Gisens Biotech	Observational	Completed	Renal Disease, Chronic, Renal Disease, End-Stage, Dialysis Patients, Urea in Blood; High, Potassium Measurement...	55	Argentina	clinicaltrials.gov
August 20, 2026	NCT07776509	A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With...	AstraZeneca	Phase 3	Recruiting	Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2	500	Argentina, Brazil, Canada, China, Denmark, Israel, Japan, Sweden, Turkey...	clinicaltrials.gov
August 20, 2026	NCT07776249	Effect of the WAIO Digital Platform on Multidimensional Wellbeing in Adults in Argentina	Instituto Tecnológico de Buenos Aires	Not applicable	Not yet recruiting	Wellbeing	2,000	Argentina	clinicaltrials.gov
August 19, 2026	NCT07774429	Evaluation of Psychophysical Responses After Mechanical Stimulation.	National Council of Scientific and Technical Research, Argentina	Not applicable	Completed	Pain Thresholds, Healthy Adult Participants	33	Argentina	clinicaltrials.gov
August 18, 2026	NCT07771400	Molecular Ovarian Cancer Assessment in LatiNoAmerican PAtients	Latin American Cooperative Oncology Group	Observational	Not yet recruiting	Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV, Fallopian Tube Cancer Stage III...	320	Argentina, Brazil, Colombia, Mexico	clinicaltrials.gov
August 12, 2026	NCT07761117	A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF	AstraZeneca	Phase 3	Recruiting	Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)	6,950	Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia...	clinicaltrials.gov
August 12, 2026	NCT07759245	A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)	Eli Lilly and Company	Phase 2	Recruiting	Pulmonary Disease, Chronic Obstructive	606	Argentina, Austria, Canada, China, Czechia, Denmark, France, Germany, Hungary...	clinicaltrials.gov
August 10, 2026	NCT07753993	A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.	AstraZeneca	Phase 3	Recruiting	Chronic Kidney Disease	7,000	Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark...	clinicaltrials.gov
August 7, 2026	NCT07753356	VALIDATION OF FUSION CEMEP SCORE FOR OMITTING SYSTEMATIC PROSTATE BIOPSY	Marcelo Ruben Oliva	Observational	Not yet recruiting	Prostate Cancer, Prostatic Neoplasms/Diagnosis	150	Argentina	clinicaltrials.gov
August 5, 2026	NCT07746687	A Study of JNJ-95597528 in Participants With Inadequately Controlled Moderate to Severe Asthma	Janssen Research & Development, LLC	Phase 2	Recruiting	Asthma	440	Argentina, China, Israel, Japan, United States	clinicaltrials.gov
August 3, 2026	NCT07742735	A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome...	VectivBio AG	Phase 3	Recruiting	Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)	124	Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, Denmark...	clinicaltrials.gov
August 3, 2026	NCT07742644	A Study on the Immune Response and Safety of an Investigational Combined Measles, Mumps, Rubella and Varicella Vaccine, When Given to...	GlaxoSmithKline	Phase 3	Not yet recruiting	Measles, Mumps, Rubella, Varicella (Chickenpox), Measles-Mumps-Rubella+Chickenpox Vaccine	1,860	Argentina, Finland, Italy, Puerto Rico, Taiwan, United States	clinicaltrials.gov
July 31, 2026	NCT07739966	A Study of DS-3939a in Participants With Solid Tumors	Daiichi Sankyo	Phase 1/2	Recruiting	Solid Tumor, Locally Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer	400	Argentina, Austria, Belgium, Brazil, China, France, Italy, Japan, Spain...	clinicaltrials.gov
July 29, 2026	NCT07734844	A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO	Kodiak Sciences Inc	Phase 3	Recruiting	Diabetic Macular Edema (DME)	910	Argentina, United States	clinicaltrials.gov
July 21, 2026	NCT07717411	A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease	Hoffmann-La Roche	Phase 3	Recruiting	Alzheimer's Disease	1,600	Argentina, Australia, Brazil, Canada, Chile, China, Japan, Taiwan, United...	clinicaltrials.gov
July 20, 2026	NCT07712861	DISON I - Directly Integrated Suction and Optics System for the Treatment of Nephrolithiasis	Ventaris Surgical Incorporated	Not applicable	Not yet recruiting	Kidney Stones, Urolithiasis, Nephrolithiasis	75	Argentina, Canada, Hong Kong, India, New Zealand	clinicaltrials.gov
July 15, 2026	NCT07705555	A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Diabetic Retinopathy, Macular Edema	960	Argentina, Australia, United Kingdom, United States	clinicaltrials.gov
July 13, 2026	NCT07700056	A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin...	Novartis Pharmaceuticals	Phase 3	Recruiting	Chronic Pruritus of Unknown Origin	180	Argentina, Canada, Japan, South Korea, United States	clinicaltrials.gov
July 10, 2026	NCT07694427	Mo-Rez in First- Line (1L) Maintenance Treatment of Non-Homologous Recombination Deficient Ovarian Cancer (Non-HRd OC) [BEHOLD-Ovarian03]	GlaxoSmithKline	Phase 3	Recruiting	Ovarian Neoplasms	720	Argentina, Australia, Canada, Japan, South Korea	clinicaltrials.gov
July 9, 2026	NCT07691970	Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From...	AstraZeneca	Phase 3	Recruiting	Systemic Sclerosis Cutaneous Lupus E Myopathies Systemic Lupus Erythematosus	1,072	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile, China...	clinicaltrials.gov
July 7, 2026	NCT07686263	Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia	Karuna Therapeutics, Inc., a Bristol Myers Squibb company	Phase 3	Recruiting	Schizophrenia	472	Argentina, Bulgaria, Czechia, Poland, Romania, Spain, United States	clinicaltrials.gov
July 6, 2026	NCT07685132	Correlation Between Carbapenemase-Producing Enterobacterales Load, Environmental Contamination, and Transmission in Critical Care Units	Hospital Italiano de Buenos Aires	Observational	Not yet recruiting	Healthcare-Associated Infections (HAIs), Carbapenem-Resistant Enterobacteriaceae Colonization, Antimicrobial Resistance...	60	Argentina	clinicaltrials.gov
July 2, 2026	NCT07681544	Empirical Meropenem Dosing in Critically Ill Patients: Early Assessment of Plasma Exposure and Minimum Inhibitory Concentration Targets	Hospital Italiano de Buenos Aires	Not applicable	Completed	Empirical Antimicrobial Therapy, Critically Ill, Meropenem, Pharmacokinetics and Pharmacodynamics	26	Argentina	clinicaltrials.gov
July 2, 2026	NCT07680790	Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination...	Bristol-Myers Squibb	Phase 3	Recruiting	Non-Small Cell Lung Cancer	850	Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy...	clinicaltrials.gov
July 2, 2026	NCT07680764	A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy...	Bristol-Myers Squibb	Phase 2	Recruiting	Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)	160	Argentina, Australia, Brazil, Chile, China, France, Germany, Italy, Romania...	clinicaltrials.gov
June 25, 2026	NCT07667803	A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM	AstraZeneca	Phase 3	Recruiting	Weight Management	4,500	Argentina, Australia, Brazil, Canada, Chile, China, Germany, India, Italy...	clinicaltrials.gov
June 24, 2026	NCT07665437	An Extension Study to Assess Safety and Efficacy of Remibrutinib in Participants With Moderate to Severe HS	Novartis Pharmaceuticals	Phase 3	Recruiting	Hidradenitis Suppurativa	710	Argentina, Australia, Canada, China, Czechia, France, Germany, Italy, Malaysia...	clinicaltrials.gov
June 23, 2026	NCT07662213	A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	1,200	Argentina, Australia, Brazil, Bulgaria, Canada, China, Germany, Hungary, Italy...	clinicaltrials.gov
June 23, 2026	NCT07662109	A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	2,000	Argentina, Brazil, China, Czechia, Denmark, Germany, Greece, Hungary, India...	clinicaltrials.gov
June 23, 2026	NCT07662044	A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo...	AstraZeneca	Phase 3	Recruiting	Type 2 Diabetes Mellitus	800	Argentina, China, Denmark, Greece, Hungary, Japan, Slovakia, South Africa...	clinicaltrials.gov
June 22, 2026	NCT07658976	Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy	HIV Prevention Trials Network	Phase 3	Not yet recruiting	HIV Infection, Sexually Transmitted Infection	400	Argentina, Brazil, Peru, United States	clinicaltrials.gov
June 18, 2026	NCT07657468	Phase II, Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Efficacy and Safety of Omega-3 Fatty Acids as an...	National University of La Rioja	Phase 2	Not yet recruiting	Pain Postoperative, Analgesia	40	Argentina	clinicaltrials.gov
June 17, 2026	NCT07652658	A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.	AstraZeneca	Phase 2	Recruiting	Idiopathic Pulmonary Fibrosis (IPF)	359	Argentina, Australia, Bulgaria, Canada, Chile, China, Denmark, France, Germany...	clinicaltrials.gov
June 17, 2026	NCT07652294	Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD	Spyre Therapeutics, Inc.	Phase 2	Enrolling by invitation	Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative	645	Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia...	clinicaltrials.gov
June 16, 2026	NCT07650916	A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With...	ViiV Healthcare	Phase 3	Recruiting	HIV Infections	564	Argentina, Australia, Brazil, Canada, Japan, Mexico, Puerto Rico, Spain, United...	clinicaltrials.gov
June 12, 2026	NCT07646587	A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)	Windward Bio	Phase 2	Recruiting	COPD (Chronic Obstructive Pulmonary Disease)	105	Argentina, United States	clinicaltrials.gov
June 12, 2026	NCT07645248	A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and...	GlaxoSmithKline	Phase 3	Recruiting	Asthma	110	Argentina, Canada, United Kingdom, United States	clinicaltrials.gov
June 12, 2026	NCT07644260	Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric Patients	Hospital de Clinicas José de San Martín	Observational	Not yet recruiting	Anesthesia, Pediatric Anesthesia, Total Intravenous Anesthesia	50	Argentina	clinicaltrials.gov
June 10, 2026	NCT07639359	Subanesthetic Ketamine Infusions for Depressive Symptoms in Intensive Care Unit Patients	Hospital Italiano de Buenos Aires	Phase 2	Recruiting	Critical Illness, Depressive Symptoms	50	Argentina, United States	clinicaltrials.gov
June 9, 2026	NCT07634783	Delta Pocc During Spontaneous Breathing Trial to Predict Extubation Failure in Mechanically Ventilated Adults (DELTA-EXT)	Sanatorio Parque, Argentina	Observational	Not yet recruiting	Mechanical Ventilation Weaning From Mechanical Ventilation Extubation Failure Critical Illness	120	Argentina	clinicaltrials.gov
June 8, 2026	NCT07634471	A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007)	Merck Sharp & Dohme LLC	Phase 2/3	Recruiting	Follicular Lymphoma	960	Argentina, Australia, Chile, China, Greece, Israel, Italy, Poland, South Korea...	clinicaltrials.gov
June 8, 2026	NCT07631338	Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies	Hospital Italiano de Buenos Aires	Observational	Recruiting	Low-grade Glioma	40	Argentina	clinicaltrials.gov
June 5, 2026	NCT07631221	Effect of Protein Dosage on Persistent Acute Renal Failure in Critically Ill Patients.	Hospital Italiano de Buenos Aires	Observational	Recruiting	Acute Kidney Failure, Critical Illness, Protein Intake, Nutritional Support, Mortality in Intensive Care Units	344	Argentina	clinicaltrials.gov
June 5, 2026	NCT07630337	Cryotherapy Versus Standard Care in Reducing Opioid Consumption After Total Knee Arthroplasty	Hospital Italiano de Buenos Aires	Not applicable	Recruiting	Osteoarthritis, Knee, Postoperative Pain, Total Knee Arthroplasty	74	Argentina	clinicaltrials.gov
June 5, 2026	NCT07629219	Optimization of Low-Value Medical Testing Practices in Hospitalized Patients in Argentina	Hospital Italiano de Buenos Aires	Not applicable	Completed	Low-Value Care, Costs and Cost Analysis, Implementation Science, Public Health, Clinical Laboratory Techniques...	600	Argentina	clinicaltrials.gov
June 3, 2026	NCT07624305	A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD)	AstraZeneca	Phase 3	Recruiting	Renal Insufficiency, Chronic	2,800	Argentina, Austria, Brazil, Bulgaria, Canada, China, France, Germany, Greece...	clinicaltrials.gov
June 3, 2026	NCT07623161	A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib	Takeda	Phase 3	Recruiting	Myelofibrosis, Anemia	324	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, Chile...	clinicaltrials.gov
June 2, 2026	NCT07621419	Study of Adult Patients Residing in Argentina Diagnosed With Type 2 Diabetes Treated With a New Formulation of Semaglutide, Both Oral and...	Hospital Italiano de Buenos Aires	Observational	Recruiting	Diabetes Mellitus	145	Argentina	clinicaltrials.gov
June 1, 2026	NCT07616739	Dolutegravir/Lamivudine in Treatment-Naïve Pregnant Women	Fundación Huésped	Phase 4	Recruiting	HIV-1-infection	210	Argentina, Brazil	clinicaltrials.gov
May 28, 2026	NCT07611409	Physiological Effects of External PEEP in Controlled Mechanical Ventiated Patients With autoPEEP	Hospital Donación Francisco Santojanni	Not applicable	Active not recruiting	Obstructive Airway Diseases	20	Argentina	clinicaltrials.gov
May 26, 2026	NCT07606365	A Study in Adults With Geographic Atrophy	Sitala Bio LTD	Phase 2	Recruiting	Geographic Atrophy	300	Argentina, Australia, Czechia, Poland, Switzerland, United Kingdom, United...	clinicaltrials.gov
May 22, 2026	NCT07601425	Harmony-HHT: ATV-1601 in Participants With Hereditary Hemorrhagic Telangiectasia (HHT)	Atavistik Bio, Inc	Phase 1/2	Recruiting	Hereditary Hemorrhagic Telangiectasia (HHT), Osler Weber Rendu Disease	100	Argentina, United States	clinicaltrials.gov
May 20, 2026	NCT07600398	ReDS-Guided Decongestion in Acute Heart Failure (ReDS-LATAM HF)	Instituto Cardiovascular de Buenos Aires	Not applicable	Active not recruiting	Acute Heart Failure (AHF)	216	Argentina	clinicaltrials.gov
May 20, 2026	NCT07598396	A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis	Hoffmann-La Roche	Phase 2	Recruiting	Lupus, Systemic Lupus Erythematosus, Lupus Nephritis	30	Argentina, Brazil, Colombia, Italy, Mexico, South Africa	clinicaltrials.gov
May 19, 2026	NCT07595042	A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 2	Not yet recruiting	Tuberculosis	900	Argentina, Australia, Botswana, Brazil, Haiti, India, Kenya, Malawi, Mexico...	clinicaltrials.gov
May 15, 2026	NCT07589634	A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants...	Janssen Research & Development, LLC	Phase 2	Recruiting	Multiple Myeloma	230	Argentina, Australia, France, Greece, Hungary, Malaysia, Portugal, Spain...	clinicaltrials.gov
May 13, 2026	NCT07585266	A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable...	GlaxoSmithKline	Phase 3	Recruiting	Gastrointestinal Stromal Neoplasms	800	Argentina, Australia, Brazil, Canada, China, Finland, France, Greece, Italy...	clinicaltrials.gov
May 11, 2026	NCT07577856	A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis	Janssen Research & Development, LLC	Phase 3	Recruiting	Colitis, Ulcerative	644	Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China...	clinicaltrials.gov
May 11, 2026	NCT07577843	A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease	Janssen Research & Development, LLC	Phase 3	Recruiting	Crohn Disease	460	Argentina, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France...	clinicaltrials.gov
May 7, 2026	NCT07573462	A Study to Learn About the Safety of an Expanded Pneumococcal Vaccine in Healthy Infants	Pfizer	Phase 3	Recruiting	Pneumococcal Disease	2,400	Argentina, Australia, Canada, Finland, Germany, Greece, Hungary, Italy, Poland...	clinicaltrials.gov
May 7, 2026	NCT07573176	A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder	Janssen Research & Development, LLC	Phase 3	Recruiting	Depressive Disorder, Major	600	Argentina, Brazil, Canada, China, Malaysia, Taiwan, United States	clinicaltrials.gov
May 6, 2026	NCT07571473	CoreSys Monitoring for Intraoperative Stress Management in Abdominal Hysterectomy	Hospital Provincial de Rosario	Not applicable	Recruiting	Surgical Stress Response, Inflammation, Anesthesia, Perioperative Care	30	Argentina	clinicaltrials.gov
May 6, 2026	NCT07569029	A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical...	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1	Recruiting	HIV	42	Argentina, Peru, United States, Zimbabwe	clinicaltrials.gov
May 5, 2026	NCT07567001	A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Heart Failure	5,610	Argentina, Australia, Brazil, Bulgaria, Canada, China, Czechia, Denmark...	clinicaltrials.gov
May 4, 2026	NCT07564414	A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or...	Novo Nordisk A/S	Phase 3	Recruiting	Obesity, Type 2 Diabetes	2,500	Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, France...	clinicaltrials.gov
April 28, 2026	NCT07554339	A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)	Merck Sharp & Dohme LLC	Phase 3	Recruiting	Non-small Cell Lung Cancer	310	Argentina, Australia, Brazil, China, France, Germany, Greece, Italy, Japan...	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
Eli Lilly and Company	34	October 28, 2026
AstraZeneca	34	October 1, 2026
Merck Sharp & Dohme LLC	34	July 15, 2026
Bristol-Myers Squibb	25	July 2, 2026
Sanofi	24	February 20, 2026
Hoffmann-La Roche	22	July 21, 2026
Boehringer Ingelheim	18	November 4, 2026
Novartis Pharmaceuticals	18	July 13, 2026
Pfizer	17	May 7, 2026
Novo Nordisk A/S	15	November 5, 2026
Hospital Italiano de Buenos Aires	15	October 15, 2026
Janssen Research & Development, LLC	15	August 5, 2026
GlaxoSmithKline	14	August 27, 2026
Amgen	8	June 25, 2025
Immunovant Sciences GmbH	6	September 23, 2025
National Council of Scientific and Technical Research, Argentina	5	October 14, 2026
Takeda	5	June 3, 2026
AbbVie	5	April 20, 2026
BeOne Medicines	5	June 29, 2025
Alexion Pharmaceuticals, Inc.	4	August 28, 2026

Conditions

Condition group	New trials	Latest
Obesity	42	November 5, 2026
Overweight	32	October 28, 2026
Carcinoma, Non-Small-Cell Lung	26	July 31, 2026
Diabetes Mellitus, Type 2	25	October 28, 2026
Hypertension	15	November 5, 2026
Pulmonary Disease, Chronic Obstructive	15	August 12, 2026
Alzheimer Disease	14	July 21, 2026
Breast Neoplasms	14	February 12, 2026
Renal Insufficiency, Chronic	13	August 25, 2026
Asthma	13	August 5, 2026
Colitis, Ulcerative	10	June 17, 2026
Lung Neoplasms	10	October 30, 2025
Cardiovascular Diseases	9	October 28, 2026
Prostatic Neoplasms	8	October 23, 2026
Heart Failure	8	August 12, 2026
Ovarian Neoplasms	7	August 18, 2026
Lung Diseases	7	August 12, 2026
Hidradenitis Suppurativa	7	June 24, 2026
Colorectal Neoplasms	7	April 24, 2026
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating	7	September 23, 2025
Cognitive Dysfunction	7	September 17, 2025
Stroke	6	October 15, 2026
Diabetes Mellitus	6	October 8, 2026
Lupus Erythematosus, Systemic	6	May 20, 2026
Lung Diseases, Interstitial	6	April 21, 2026

By phase

Phase	New trials	Latest
Phase 3	262	November 5, 2026
Phase 2	106	October 22, 2026
Observational	71	October 30, 2026
Not applicable	43	October 15, 2026
Phase 2/3	20	June 8, 2026
Phase 1/2	14	July 31, 2026
Phase 4	9	November 9, 2026
Phase 1	4	May 6, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.